000 01237 a2200337 4500
005 20250516011804.0
264 0 _c20101112
008 201011s 0 0 eng d
022 _a1533-4406
024 7 _a10.1056/NEJMc1009551
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPlotkin, Stanley A
245 0 0 _aPoliovirus vaccine and vaccine-derived polioviruses.
_h[electronic resource]
260 _bThe New England journal of medicine
_c11 2010
300 _a1870; author reply 1870-1 p.
_bdigital
500 _aPublication Type: Letter; Comment
650 0 4 _aAntibodies, Viral
_xblood
650 0 4 _aDeveloping Countries
650 0 4 _aHumans
650 0 4 _aImmunization Programs
650 0 4 _aIntestines
_xvirology
650 0 4 _aPoliomyelitis
_xprevention & control
650 0 4 _aPoliovirus
_ximmunology
650 0 4 _aPoliovirus Vaccine, Inactivated
_xeconomics
650 0 4 _aPoliovirus Vaccine, Oral
_xadverse effects
650 0 4 _aVaccination
_xadverse effects
650 0 4 _aVaccines, Combined
650 0 4 _aVirulence
773 0 _tThe New England journal of medicine
_gvol. 363
_gno. 19
_gp. 1870; author reply 1870-1
856 4 0 _uhttps://doi.org/10.1056/NEJMc1009551
_zAvailable from publisher's website
999 _c20346554
_d20346554